P70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation

Molecular Oncology

Volumn 8, Issue 3, 2014, Pages 766-780

  Segatto, Ilenia ^a   Berton, Stefania ^a   Sonego, Maura ^a   Massarut, Samuele ^a   Fabris, Linda ^a   Armenia, Joshua ^a   Mileto, Mario ^a   Colombatti, Alfonso ^a,b   Vecchione, Andrea ^c   Baldassarre, Gustavo ^a   Belletti, Barbara ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Breast cancer; MTOR; P70S6K; Proliferation; Survival; Xenograft

Indexed keywords

P70S6 KINASE; PROTEIN BCL 2; RIBOSOME PROTEIN; UNCLASSIFIED DRUG; S6 KINASE; TARGET OF RAPAMYCIN KINASE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CELL SURVIVAL; CELLS; CLONOGENIC ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURGICAL WOUND; WOUND FLUID; ANIMAL; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; METABOLISM; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SURGERY; TUMOR CELL LINE; TUMOR INVASION; TUMOR RECURRENCE;

MUS MUSCULUS;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84899493063     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.02.006     Document Type: Article

References (37)

1. Abdulkarim B.S., Cuartero J., Hanson J., Deschênes J., Lesniak D., Sabri S. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J.Clin. Oncol. 2011, 29:2852-2858.
2. Akar U., Ozpolat B., Mehta K., Lopez-Berestein G., Zhang D., Ueno N.T., Hortobagyi G.N., Arun B. Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol. Cancer Ther. 2010, 9:1180-1187.
3. Baker D.G., Masterson T.M., Pace R., Constable W.C., Wanebo H. The influence of the surgical wound on local tumor recurrence. Surgery 1989, 106:525-532.
4. Baldassarre G., Belletti B., Nicoloso M.S., Schiappacassi M., Vecchione A., Spessotto P., Morrione A., Canzonieri V., Colombatti A. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 2005, 7:51-63.
5. Belletti B., Nicoloso M.S., Schiappacassi M., Berton S., Lovat F., Wolf K., Canzonieri V., D'Andrea S., Zucchetto A., Friedl P., Colombatti A., Baldassarre G. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol. Biol. Cell 2008, 19:2003-2013.
6. Belletti B., Vaidya J.S., D'Andrea S., Entschladen F., Roncadin M., Lovat F., Berton S., Perin T., Candiani E., Reccanello S., Veronesi A., Canzonieri V., Trovò M.G., Zaenker K.S., Colombatti A., Baldassarre G., Massarut S. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin. Cancer Res. 2008, 14:1325-1332.
7. Belletti B., Pellizzari I., Berton S., Fabris L., Wolf K., Lovat F., Schiappacassi M., D'Andrea S., Nicoloso M.S., Lovisa S., Sonego M., Defilippi P., Vecchione A., Colombatti A., Friedl P., Baldassarre G. p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol. Cell. Biol. 2010, 30:2229-2240.
8. Benson J.R., Jatoi I., Keisch M., Esteva F.J., Makris A., Jordan V.C. Early breast cancer. Lancet 2009, 373:1463-1479.
9. Bigelow R.L., Chari N.S., Unden A.B., Spurgers K.B., Lee S., Roop D.R., Toftgard R., McDonnell T.J. Transcriptional regulation of bcl-2 mediated by the sonic Hedgehog signaling pathway through gli-1. J.Biol. Chem. 2004, 279:1197-1205.
10. Bissell M.J., Hines W.C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 2011, 17:320-329.
11. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70.
12. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., Godwin J., Gray R., Hicks C., James S., MacKinnon E., McGale P., McHugh T., Peto R., Taylor C., Wang Y. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
13. Couch F.J., Wang X.Y., Wu G.J., Qian J., Jenkins R.B., James C.D. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer. Cancer Res. 1999, 59:1408-1411.
14. Demicheli R., Valagussa P., Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases?. Br. J. Cancer 2001, 85:490-492.
15. Demicheli R., Retsky M.W., Hrushesky W.J., Baum M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat. Clin. Pract. Oncol. 2007, 12:699-710.
16. Düvel K., Yecies J.L., Menon S., Raman P., Lipovsky A.I., Souza A.L., Triantafellow E., Ma Q., Gorski R., Cleaver S., Vander Heiden M.G., MacKeigan J.P., Finan P.M., Clish C.B., Murphy L.O., Manning B.D. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 2010, 39:171-183.
17. Fenton T.,R., Gout I.T. Functions and regulation of the 70kDa ribosomal S6 kinase. Int. J. Biochem. Cell Biol. 2011, 43:47-59.
18. Fingar D.C., Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004, 23:3151-3171.
19. Ghayad S.E., Cohen P.A. Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients. Recent Pat. Anticancer Drug Discov. 2010, 5:29-57.
20. Gruber Filbin M., Dabral S.K., Pazyra-Murphy M.F., Ramkissoon S., Kung A.L., Pak E., Chung J., Theisen M.A., Sun Y., Franchetti Y., Sun Y., Shulman D.S., Redjal N., Tabak B., Beroukhim R., Wang Q., Zhao J., Dorsch M., Buonamici S., Ligon K.L., Kelleher J.F., Segal R.A. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. Nat. Med. 2013, 19:1518-1523.
21. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004, 18:1926-1945.
22. Huston T.L., Simmons R.M. Locally recurrent breast cancer after conservation therapy. Am. J. Surg. 2005, 189:229-235.
23. Jefferies H.B., Fumagalli S., Dennis P.B., Reinhard C., Pearson R.B., Thomas G. Rapamycin suppresses 5' TOP mRNA translation through inhibition of p70S6K. EMBO J. 1997, 16:3693-3704.
24. Kawasome H., Papst P., Webb S., Keller G.M., Johnson G.L., Gelfand E.W., Terada N. Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5033-5038.
25. Maruani D.M., Spiegel T.N., Harris E.N., Shachter A.S., Unger H.A., Herrero-Gonzlez S., Holz M.K. Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation. Oncogene 2012, 31:5073-5080.
26. Monni O., Barlund M., Mousses S., Kononen J., Sauter G., Heiskanen M., Paavola P., Avela K., Chen Y., Bittner M.L., Kallioniemi A. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5711-5716.
27. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.P., Tong F., Speed T., Spellman P.T., DeVries S., Lapuk A., Wang N.J., Kuo W.L., Stilwell J.L., Pinkel D., Albertson D.G., Waldman F.M., McCormick F., Dickson R.B., Johnson M.D., Lippman M., Ethier S., Gazdar A., Gray J.W. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527.
28. Ng J.M., Curran T. The Hedgehog's tale: developing strategies for targeting cancer. Nat. Rev. Cancer 2011, 11:493-501.
29. Pearce L.R., Alton G.R., Richter D.T., Kath J.C., Lingardo L., Chapman J., Hwang C., Alessi D.R. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem. J. 2010, 431:245-255.
30. Pearce L.R., Komander D., Alessi D.R. The nuts and the bolts of AGC protein kinases. Nat. Rev. Mol. Cell. Biol. 2010, 11:9-22.
31. Schalm S.S., Blenis J. Identification of a conserved motif required for mTOR signaling. Curr. Biol. 2002, 12:632-639.
32. Segatto I., Berton S., Sonego M., Massarut S., D'Andrea S., Perin T., Fabris L., Armenia J., Rampioni G., Lovisa S., Schiappacassi M., Colombatti A., Bristow R.G., Vecchione A., Baldassarre G., Belletti B. Inhibition of breast cancer local relapse by targeting p70S6 kinase activity. J.Mol. Cell Biol. 2013, 6:428-431.
33. Shin S., Wolgamott L., Yu Y., Blenis J., Yoon S.O. Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:E1204-E1213.
34. Tagliabue E., Agresti R., Carcangiu M.L., Ghirelli C., Morelli D., Campiglio M., Martel M., Giovanazzi R., Greco M., Balsari A., Ménard S. Role of HER2 in wound-induced breast carcinoma proliferation. Lancet 2003, 362:527-533.
35. van der Hage J.A., van den Broek L.J., Legrand C., Clahsen P.C., Bosch C.J., Robanus-Maandag E.C., van de Velde C.J., van de Vijver M.J. Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients. Br. J. Cancer 2004, 90:1543-1550.
36. von Manteuffel S.R., Dennis P.B., Pullen N., Gingras A.C., Sonenberg N., Thomas G. The insulin-induced signaling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70S6K. Mol. Cell. Biol. 1997, 17:5426-5436.
37. Wang Y., Ding Q., Yen C.J., Xia W., Izzo J.G., Lang J.Y., Li C.W., Hsu J.L., Miller S.A., Wang X., Lee D.F., Hsu J.M., Huo L., Labaff A.M., Liu D., Huang T.H., Lai C.C., Tsai F.J., Chang W.C., Chen C.H., Wu T.T., Buttar N.S., Wang K.K., Wu Y., Wang H., Ajani J., Hung M.C. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell 2012, 21:374-387.